For latest information on South African COVID-19 Resource Portal go to sacoronavirus.co.za
Toggle Bar

Aurum Mozambique

The Aurum Institute Mozambique office was established in 2019 and is leading the IMPAACT4TB project in the Southern African country.

It is part of an international consortium working on the project which will prioritise short-course TB preventive therapy for people living with HIV and children under five years old, and subsequently all those in close contact with TB patients in 12 high-burden countries. These are South Africa, Ghana and Mozambique, Brazil, Ethiopia, Kenya, Tanzania, Malawi, Zimbabwe, India, Cambodia and Indonesia, which represent 50 percent of the global TB burden.

Our Team

Image
Emilio Valverde
Country Director
Image
Agagá Tembe Cuambe
Finance and Operations Manager
Image
Nárcia Zubaida
Office Manager
Image
Dr Savaiva Munguambe
Programme Manager
Image
Dr Elzier Mangunyane
Programme Manager
Image
Dr Sheila Cassamo
Project Coordinator
Image
Ms Maria Matsinhe
Project Coordinator
Image
Mr Daniel Cuateia
Pharmacist
Image
Dr Marta Banguine
HR Officer
Image
Mr Arlindo Miguel
Monitoring and Evaluation
Image
Mr Augusto Savela
Research Nurse
Image
Mr Issufo Bica
Research Nurse
Image
Mr Manuel Muamede
Research Nurse
Image
Ms Ivete Andrade
Research Nurse
Image
Ms Mindoca Jalane
Research Nurse
Image
Ms Uwimana Berthilde
Clinical Assoociate
Image
Mr Luis Alfandiga
Finance Officer
Image
Mr Evandro Ubisse
Finance Assistant
Image
Mr Salvino Notico
Data Capturer
Image
Ms Celina Fulane
Administrator
Image
Ms Lucilia Baptista
Research Assistant
Image
Rogério Chiau
Study Coordinator
Image
Júlio Mussane
Driver
Avaliação e manejo de pacientes com

Aurum Institute
Mozambique

(+258) 82 323 2220

aurummoz@auruminstitute.org

396 Amilcar Cabral Avenue
Bairro Central
Maputo.

Aurum Mozambique also supports the Ministry of Health’s National TB and HIV programmes, focusing on diagnosis and treatment. The partnership has been so fruitful that experts from the office are now part of technical groups within these government programmes.

In addition, their work focuses on assisting with high-risk groups- MDR and XDR TB- with diagnosis and treatment and implementation of quality improvement programmes.